NUVB Quarterly Results Disclosure

Nuvation Bio Inc. filed this 8-K on November 3, 2025, reporting on Item 2.02.

The filing announces the issuance of the press release detailing financial results for the quarter ended September 30, 2025.

Critical Action: Investors must consult Exhibit 99.1 (the furnished press release) for specific financial performance data, operational metrics, and any forward-looking guidance, as the results are not summarized within the 8-K body itself.

• Exchange Listings: Class A Common Stock (NUVB) and Redeemable Warrants (NUVB.WS) are regist